Tilray logo
TLRYTilray
Trade TLRY now
Tilray primary media

About Tilray

Tilray (NASDAQ:TLRY) specializes in cannabis research, cultivation, production, and distribution, aiming to lead and legitimize the rapidly expanding global cannabis industry. The company is traded on the NASDAQ under the ticker symbol TLRY. With a focus on both medicinal and recreational cannabis products, Tilray is dedicated to innovative growth strategies and enhancing consumer experiences while adhering to stringent quality control measures. Its operations span multiple countries, allowing for a diversified and strategic approach to market penetration and scalability. Tilray's projects vary from developing new cannabis strains to environmental sustainability efforts within the cannabis production process. Objectively, Tilray strives to set industry standards in product quality, customer satisfaction, and regulatory compliance, underscoring its commitment to leading the transformation of the cannabis sector into a mainstream, legally recognized marketplace.

What is TLRY known for?

Snapshot

Public US
Ownership
2013
Year founded
958
Employees
New York, United States
Head office
1 of 2
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
New York City, US

Produtos e/ou serviços de Tilray

  • Medical cannabis products and services including a range of cannabis strains and pharmaceutical-grade cannabis extracts for patients in various countries.
  • Recreational cannabis offering a variety of adult-use cannabis brands and products across different markets.
  • Hemp-based food products under the brand Manitoba Harvest, providing a wide range of hemp granola, hemp hearts, and hemp protein powders.
  • Craft beer through SweetWater Brewing Company, focusing on cannabis-inspired and traditional beers.
  • Cannabis lifestyle and wellness brand Marley Natural, offering smoking accessories, body care products, and cannabis based on the legacy of Bob Marley.
  • International expansion projects, aiming to strengthen its presence in the global medical cannabis market by entering new countries and forming strategic partnerships.

equipe executiva do Tilray

  • Mr. Irwin David SimonPresident, CEO & Chairman
  • Mr. Carl A. Merton CA, CBV, CPACFO & Principal Accounting Officer
  • Mr. Roger SavellChief Administrative Officer & CFO of International
  • Mr. Mitchell S. Gendel J.D.Global General Counsel & Corporate Secretary
  • Ms. Denise Menikheim FaltischekChief Strategy Officer and Head of M&A
  • Mr. Lloyd BrathwaiteChief Information Officer
  • Ms. Nyree PintoChief Human Resources Officer
  • Ms. Berrin NoorataChief Corporate Affairs Officer
  • Mr. Blair MacNeil CMA, CPAPresident of Tilray Canada
  • Mr. Ty H. GilmorePresident of U.S. Beer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.